Literature DB >> 9684136

The usefulness of radiation therapy for hepatocellular carcinoma.

M Matsuura1, N Nakajima, K Arai, K Ito.   

Abstract

BACKGROUND/AIMS: The usefulness of radiation therapy (RT) for hepatocellular carcinoma (HCC) is still controversial. To clarify whether RT has its role in the management of HCC as a single modality or in combination with other modalities, we analyzed the clinical features of the patients treated with RT retrospectively.
METHODOLOGY: Twenty-two patients who underwent RT for intrahepatic lesions with total dose ranging from 58 to 68 Gy were studied. Regression rate for 21 of the irradiated lesions was calculated using the computed tomographic scans.
RESULTS: After the size of the irradiated intrahepatic tumor initially decreased, it remained unchanged for a long period. Tumor size at the latest follow-up never exceeded pre-RT tumor size except in one patient who was treated by RT only. In 3 of 20 cancer deaths, the irradiated tumors were the direct cause of death.
CONCLUSION: Local RT for HCC at potentially curative dose can be performed safely in patients with preserved liver function even if they have already been treated with other therapies. Radiation therapy has a role in strengthening the therapeutic efficacy when combined with other therapy.

Entities:  

Mesh:

Year:  1998        PMID: 9684136

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Radioresponse of hepatocellular carcinoma-treatment of lymph node metastasis.

Authors:  Sang Min Yoon; Jong Hoon Kim; Eun Kyung Choi; Seung Do Ahn; Sang-wook Lee; Byong Yong Yi; Young Wha Chung; Young Sang Lee; Dong Jin Seo
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

2.  Retrospective evaluation of tumor-mass-reduction therapy for the prognosis of recurrent hepatocellular carcinoma.

Authors:  Emiko Mikami; Noriatsu Kanno; Yoshiyuki Ueno; Tooru Shimosegawa
Journal:  Hepatol Int       Date:  2007-10-18       Impact factor: 6.047

3.  Transcatheter arterial chemoembolisation followed by three-dimensional conformal radiotherapy versus transcatheter arterial chemoembolisation alone for primary hepatocellular carcinoma in adults.

Authors:  Liming Lu; Jingchun Zeng; Zehuai Wen; Chunzhi Tang; Nenggui Xu
Journal:  Cochrane Database Syst Rev       Date:  2019-02-16

4.  Development of ti-coated ferromagnetic needle, adaptable for ablation cancer therapy by high-frequency induction heating.

Authors:  Takashi Naohara; Hiromichi Aono; Tsunehiro Maehara; Hideyuki Hirazawa; Shinya Matsutomo; Yuji Watanabe
Journal:  J Funct Biomater       Date:  2012-03-06

5.  Combination of macrophage inflammatory protein 1 alpha with existing therapies to enhance the antitumor effects on murine hepatoma.

Authors:  Keun-Yeong Jeong; Eun-Jung Lee; Seung-Hyun Yang; Jinsil Seong
Journal:  J Radiat Res       Date:  2014-09-15       Impact factor: 2.724

6.  Effects of TACE combined with precise RT on p53 gene expression and prognosis of HCC patients.

Authors:  Yupeng Liu; Jingchen Yan; Feng Wang
Journal:  Oncol Lett       Date:  2018-08-30       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.